ROCKLAGE SCOTT M

Track

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
ROCKLAGE SCOTT M's trades of Aprea Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-06-18 2020-06-16
S Sale
34,041 -27.6%
322.85
US$1,806,593 		34,041 -27.6% 322.85 US$1,806,593
2020-06-18 2020-06-16
S Sale
38,686 +31.7%
75.20
US$3,486,006 		38,686 +31.7% 75.20 US$3,486,006
2020-06-15 2020-06-11
S Sale
8,207 -8.2%
150.67
US$4,911,932 		8,207 -8.2% 150.67 US$4,911,932
2020-06-15 2020-06-11
S Sale
235,200 -10.8%
28.75
US$6,762,635 		235,200 -10.8% 28.75 US$6,762,635
2020-05-21 2020-05-19
S Sale
10,200 -10.1%
35.15
US$358,530 		10,200 -10.1% 35.15 US$358,530
2020-05-21 2020-05-19
S Sale
244,800 -10.1%
35.15
US$8,604,720 		244,800 -10.1% 35.15 US$8,604,720